Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
Grant Opportunity Analysis
The Centers for Disease Control and Prevention, through NIOSH, is offering R21 exploratory and developmental grants for research related to the World Trade Center Health Program. The program supports early-stage studies aimed at improving diagnosis, treatment, and overall care for individuals exposed to the September 11, 2001 attacks, especially where there is diagnostic or treatment uncertainty. Projects may run up to two years, should align with CDC priorities and focus on relevant 9/11-exposed populations and study areas, and are expected to be based on minimal or no preliminary data. Applications are due June 23, 2026, December 8, 2026, and October 26, 2027 by 11:59 pm local time of the applicant organization; no cost sharing is required, the award ceiling is $365,000, and the scientific program official is James Yiin at jcy5@cdc.gov.
Eligible Applicants
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.